Hyphens Pharma International Limited’s subsidiary, Hyphens Pharma, has obtained an exclusive right to market Metoject.

The treatment pen, called Metroject, is already a first-line treatment for rheumatoid arthritis in Europe and America.

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS Pharmaceuticals received the green light from health regulators for a needle ...

Surging Demand for Insulin Dosing Precision: With 35 million insulin-dependent patients worldwide, healthcare systems are prioritizing smart syringes equipped with real-time monitoring. Mobile health ...

The American pharmaceutical company has started selling higher doses of Zepbound, as it seeks to spur demand for the medicine ...

Eli Lilly began offering vials of the two lowest doses of Zepbound, which is typically sold in auto-injector pens, in August last year. On Tuesday, it said it had cut the prices for a month's ...